In July 2025, Novartis Pharmaceuticals announced a phase III study to assess efficacy and safety of crizanlizumab (5 mg/kg) ...

Breakthrough AI-powered genome editing tools now enable full chromosome manipulation—ushering in a new era of gene therapy and bioethics.

The viruses that kill bacteria may be our best bet against antibiotic resistance – if we can understand how they win.

Discover how ABC transporters could offer a targeted approach to tackle drug-resistant bacteria and combat antimicrobial ...

Is there an effective alternative to antibiotics? Researchers around the world are focusing on bacteriophages. These "good" ...

Christina Simms wouldn’t call herself an artist. The Howard University student was a budding scientist visiting to do ...

The viruses that kill bacteria may be our best bet against antibiotic resistance — if we can understand how they win.

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

Patricia Bondia, a biotechnologist turned science illustrator, develops video games based on scientific concepts to connect ...

Thirty years ago a doctor named Mark Geier spread fears about vaccines and autism. Now his son, David, is reportedly looking ...

Although in some countries Bactitophages have not been adopted as a conventional treatment, there remains no doubt as to its potential. With increased awareness, research backing, and clinical ...